Drug Discovery · Del Mar, CA · Founded 2014 · Privately Held (backing)
Developer of a eyecare medicine and drug designed to treat myopia. Sydnexis is based in Del Mar, CA and was founded in 2014. Its last reported valuation was $90 million in Aug 2021. It has raised $76.5 million across 4 recorded rounds; the latest was a $20 million early-stage round in Apr 2025.
Last reported valuation
$90.0M
Oct 2026
Priced at
—
Total raised
$76.5M
Last round
Early Stage VC
Apr 2025
Team — not yet on record
No current team members for Sydnexis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sydnexis with a free account
·Watch Sydnexis: the Monday email on marks, rounds and moves
